Sanofi ADR Inc. (SNY) Price Performance: A Fundamental Analysis Perspective

TOST Stock

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Until today this year the stock’s price performance recorded an increase of 2.60%. However, over the last six months, the performance has been weaker by 2.35%. The price of SNY decreased -9.95% over the last 30 days. And in the last five days, it has fallen by -5.76%.

Sanofi ADR experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $60.12 on 03/10/25, while the lowest price for the same period was registered at $45.80 on 12/16/24.

52-week price history of SNY Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Sanofi ADR’s current trading price is -17.68% away from its 52-week high, while its distance from the 52-week low is 8.05%. The stock’s price range during this period has varied between$45.80 and $60.12. The Sanofi ADR’s shares, which operate in the Healthcare, saw a trading volume of around 2.31 million for the day, a figure considerably lower than their average daily volume of 2.92 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Sanofi ADR (SNY) has experienced a quarterly decline of -9.15% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 120.57B and boasts a workforce of 84587 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 53.39, with a change in price of +1.33. Similarly, Sanofi ADR recorded 2,733,555 in trading volume during the last 100 days, posting a change of +2.76%.

SNY’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for SNY stands at 0.23. Similarly, the long-term debt-to-equity ratio is also 0.17.

SNY Stock Stochastic Average

As of today, Sanofi ADR’s raw stochastic average for the last 50 days stands at 17.03%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 12.53%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 37.46% and 45.88%, respectively.

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.